Moolec Science (MLEC) EBITDA Margin (2022 - 2024)
Moolec Science (MLEC) reported EBITDA Margin of 77.92% for Q4 2024, up 63328.0% on a YoY basis from N/an in Q1 2024, and up 42.26% sequentially from 134.97% in Q3 2024.
Moolec Science (MLEC) EBITDA Margin (2022 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of EBITDA Margin data on file, last reported at 77.92% in Q4 2024.
- For the quarter ending Q4 2024, EBITDA Margin rose 63328.0% year-over-year to 77.92%; the trailing twelve-month figure through Dec 2024 stood at 116.72% (down 14997.0% YoY), and the FY2024 full-year result was 160.76%, up 57443.0% from the prior year.
- EBITDA Margin grew to 77.92% in Q4 2024, from 134.97% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 6246.22% in Q3 2022 to a low of 63974.35% in Q2 2022.
- A 3-year average of 3939.29% and a median of 87.35% in 2024 frame the typical range for EBITDA Margin.
- Peak annual rise in EBITDA Margin reached 6398769 bps in 2023, while the deepest fall reached 637655 bps in 2023.
- Tracing MLEC's EBITDA Margin over 3 years: stood at 4943.14% in 2022, then plunged by 114 bps to 711.2% in 2023, then jumped by 89 bps to 77.92% in 2024.
- Business Quant data shows MLEC's EBITDA Margin at 77.92% in Q4 2024, 134.97% in Q3 2024, and 193.03% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 16.51% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -77.92% |
| Sep 30, 2024 | -134.97% |
| Jun 30, 2024 | -193.03% |
| Mar 31, 2024 | -96.78% |
| Dec 31, 2023 | -711.20% |
| Sep 30, 2023 | -130.34% |
| Jun 30, 2023 | 13.34% |
| Mar 31, 2023 | 4,893.20% |
| Dec 31, 2022 | 4,943.14% |
| Sep 30, 2022 | 6,246.22% |
| Jun 30, 2022 | -63,974.35% |
| Mar 31, 2022 | 1,951.15% |